16
Views
4
CrossRef citations to date
0
Altmetric
Research Article

DNA Ploidy and S-phase Fraction as Predictive Factors of Response and Outcome Following Neoadjuvant Methotrexate, Vinblastine, Epirubicin and Cisplatin (M-VEC) Chemotherapy for Invasive Bladder Cancer

, , , &
Pages 46-51 | Published online: 09 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Silvia Carloni, Giulia Gallerani, Anna Tesei, Emanuela Scarpi, Giorgio Maria Verdecchia, Salvatore Virzì, Francesco Fabbri & Chiara Arienti. (2017) DNA ploidy and S-phase fraction analysis in peritoneal carcinomatosis from ovarian cancer: correlation with clinical pathological factors and response to chemotherapy. OncoTargets and Therapy 10, pages 4657-4664.
Read now

Articles from other publishers (3)

Liang Cheng, Antonio Lopez‐Beltran & David G. Bostwick. 2012. Bladder Pathology. Bladder Pathology 655 678 .
C. Deliveliotis, J. Georgoulakis, A. Skolarikos, N. Trakas, J. Varkarakis, S. Albanis, B. Protogerou & A. Bamias. (2004) DNA ploidy as a prognostic factor in muscle invasive transitional cell carcinoma of the bladder. Urological Research 33:1, pages 39-43.
Crossref
F. Steffen Krause, Gerhard Feil, Karl-H. Bichler, Karl M. Schrott & Ziya Y. Akcetin. (2003) Clinical Aspects for the Use of DNA Image Cytometry in Detection of Bladder Cancer: A Valuable Tool?. DNA and Cell Biology 22:11, pages 721-725.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.